Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Antitumor effects of oncolytic adenovirus armed with Drosophila melanogaster deoxyribonucleoside kinase in colorectal cancer.
Ma S, Qu W, Mao L, Zhu Z, Jia L, Zhao L, Zheng X.
Oncol Rep. 2012 May;27(5):1443-50. doi: 10.3892/or.2012.1665. Epub 2012 Jan 27.
Related citations
Differential staining of γ synuclein in poorly differentiated compared to highly differentiated colon cancer cells.
Amsterdam A, Shezen E, Raanan C, Schreiber L, Slilat Y, Fabrikant Y, Melzer E.
Oncol Rep. 2012 May;27(5):1451-4. doi: 10.3892/or.2012.1658. Epub 2012 Jan 26.
Prognostic significance of CTCs and CSCs of tumor drainage vein blood in Dukes' stage B and C colorectal cancer patients.
Shimada R, Iinuma H, Akahane T, Horiuchi A, Watanabe T.
Oncol Rep. 2012 Apr;27(4):947-53. doi: 10.3892/or.2012.1649. Epub 2012 Jan 19.
Prognostic significance of PDCD4 expression and association with microRNA-21 in each Dukes' stage of colorectal cancer patients.
Horiuchi A, Iinuma H, Akahane T, Shimada R, Watanabe T.
Oncol Rep. 2012 May;27(5):1384-92. doi: 10.3892/or.2012.1648. Epub 2012 Jan 19.
Widdrol induces apoptosis via activation of AMP-activated protein kinase in colon cancer cells.
Kang MR, Park SK, Lee CW, Cho IJ, Jo YN, Yang JW, Kim JA, Yun J, Lee KH, Kwon HJ, Kim BW, Lee K, Kang JS, Kim HM.
Oncol Rep. 2012 May;27(5):1407-12. doi: 10.3892/or.2012.1644. Epub 2012 Jan 19.
Clinical significance of mitochondrial transcription factor A expression in patients with colorectal cancer.
Nakayama Y, Yamauchi M, Minagawa N, Torigoe T, Izumi H, Kohno K, Yamaguchi K.
Oncol Rep. 2012 May;27(5):1325-30. doi: 10.3892/or.2012.1640. Epub 2012 Jan 16.
Natural history of human aberrant crypt foci and correlation with risk factors for colorectal cancer.
Ohkubo H, Takahashi H, Yamada E, Sakai E, Higurashi T, Uchiyama T, Hosono K, Endo H, Taguri M, Nakajima A.
Oncol Rep. 2012 May;27(5):1475-80. doi: 10.3892/or.2012.1631. Epub 2012 Jan 12.
Carnosic acid inhibits the proliferation and migration capacity of human colorectal cancer cells.
Barni MV, Carlini MJ, Cafferata EG, Puricelli L, Moreno S.
Oncol Rep. 2012 Apr;27(4):1041-8. doi: 10.3892/or.2012.1630. Epub 2012 Jan 11.
Downregulation of S100A4 expression by RNA interference suppresses cell growth and invasion in human colorectal cancer cells.
Huang L, Xu Y, Cai G, Guan Z, Cai S.
Oncol Rep. 2012 Apr;27(4):917-22. doi: 10.3892/or.2011.1598. Epub 2011 Dec 20.
Koetjapic acid, a natural triterpenoid, induces apoptosis in colon cancer cells.
Nassar ZD, Aisha AF, Idris N, Khadeer Ahamed MB, Ismail Z, Abu-Salah KM, Alrokayan SA, Shah Abdul Majid AM.
Oncol Rep. 2012 Mar;27(3):727-33. doi: 10.3892/or.2011.1569. Epub 2011 Nov 30.
microRNA-320a inhibits tumor invasion by targeting neuropilin 1 and is associated with liver metastasis in colorectal cancer.
Zhang Y, He X, Liu Y, Ye Y, Zhang H, He P, Zhang Q, Dong L, Liu Y, Dong J.
Oncol Rep. 2012 Mar;27(3):685-94. doi: 10.3892/or.2011.1561. Epub 2011 Nov 23.
The global histone modification pattern correlates with overall survival in metachronous liver metastasis of colorectal cancer.
Tamagawa H, Oshima T, Shiozawa M, Morinaga S, Nakamura Y, Yoshihara M, Sakuma Y, Kameda Y, Akaike M, Masuda M, Imada T, Miyagi Y.
Oncol Rep. 2012 Mar;27(3):637-42. doi: 10.3892/or.2011.1547. Epub 2011 Nov 10.
Novel gene hBiot2 is an independent prognostic factor in colorectal cancer patients.
Shen YM, Arbman G, Sandström P, Gullstrand P, Wei YQ, Zhang H, Rosell J, Olsson B, Peng F, Yang HS, Wang CT, Sun XF.
Oncol Rep. 2012 Feb;27(2):376-82. doi: 10.3892/or.2011.1521. Epub 2011 Oct 24.
Radiation induces epithelial-mesenchymal transition in colorectal cancer cells.
Kawamoto A, Yokoe T, Tanaka K, Saigusa S, Toiyama Y, Yasuda H, Inoue Y, Miki C, Kusunoki M.
Oncol Rep. 2012 Jan;27(1):51-7. doi: 10.3892/or.2011.1485. Epub 2011 Oct 3.
PRL-3 promotes the proliferation of LoVo cells via the upregulation of KCNN4 channels.
Lai W, Chen S, Wu H, Guan Y, Liu L, Zeng Y, Zhao H, Jiang J, Chu Z.
Oncol Rep. 2011 Oct;26(4):909-17. doi: 10.3892/or.2011.1366. Epub 2011 Jun 28.
Stage II/III cancer of the rectosigmoid junction: an independent tumor type?
Mukai M, Kishima K, Yamazaki M, Aoki H, Izumi H, Yamamoto S, Tajima T, Tobita K, Sadahiro S, Yasuda S, Ogoshi K.
Oncol Rep. 2011 Sep;26(3):737-41. doi: 10.3892/or.2011.1343. Epub 2011 Jun 8.
MHC class II genotype- and MHC class I and II phenotype-related parameters in sporadic colorectal cancer.
Wolkersdörfer T, Füssel M, Kiesslich T, Neureiter D, Berr F, Aust D, Wolkersdörfer GW.
Oncol Rep. 2011 Nov;26(5):1165-71. doi: 10.3892/or.2011.1427. Epub 2011 Aug 19.
Acetylbritannilactone suppresses growth via upregulation of krüppel-like transcription factor 4 expression in HT-29 colorectal cancer cells.
Fang XM, Liu B, Liu YB, Wang JJ, Wen JK, Li BH, Han M.
Oncol Rep. 2011 Nov;26(5):1181-7. doi: 10.3892/or.2011.1411. Epub 2011 Aug 2.
Expression of p53 and DR5 in normal and malignant tissues of colorectal cancer: correlation with advanced stages.
Perraud A, Akil H, Nouaille M, Petit D, Labrousse F, Jauberteau MO, Mathonnet M.
Oncol Rep. 2011 Nov;26(5):1091-7. doi: 10.3892/or.2011.1404. Epub 2011 Jul 26.
Epigenetic silencing of microRNA-373 plays an important role in regulating cell proliferation in colon cancer.
Tanaka T, Arai M, Wu S, Kanda T, Miyauchi H, Imazeki F, Matsubara H, Yokosuka O.
Oncol Rep. 2011 Nov;26(5):1329-35. doi: 10.3892/or.2011.1401. Epub 2011 Jul 22.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on